Top Health-care stocks:
JNJ: -0.1%
PFE: -0.3%
ABT: flat
MRK: flat
AMGN: flat
Health-care shares were generally unchanged in pre-market trade Monday.
In health-care stocks news, Shares of Neothetics Inc. ( NEOT ) gained pre-market Monday after the company said it is commencing two pivotal Phase 3 trials to determine the efficacy, safety and tolerability of LIPO-202 for reducing central abdominal bulging. The specialty pharmaceutical firm said the two trials will be conducted in approximately 80 sites across the U.S and enroll a total of 1,600 patients.
Shares in the company were trading 1.2% higher at $8.25 during pre-market trading . Over the past 52 weeks, the company has traded between $6.11 and $14.10.
AEterna Zentaris ( AEZS ) said Monday it plans to conduct a phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), an orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency ( AGHD ). The study will also evaluate the effects of Macrilen on myocardial repolarization.
Shares in the company were trading 4.8% higher at $0.54 during pre-market trading. Over the past 52 weeks, the company has traded between $0.48 and $1.54.
And Recro Pharma ( REPH ), a development stage biopharmaceutical company, said Monday it has completed its previously announced acquisition of assets from Ireland-based Alkermes plc ( ALKS ) and its affiliates.
Shares in the company were unchanged at $11.17 during pre-market trading. Over the past 52 weeks, the company has traded between $2.36 and $11.70.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
